4
Changes in Ownership
Guardant Health, Inc. Filed Acc 0001576280-25-000181
Director sold 2,626 shares at $49.70 ($130,512)
- Director acquired 6,743 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
POTTER MYRTLE S · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,674 | 20,737 | D | ||
| 2025-06-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +69 | 20,806 | D | ||
| 2025-06-16 | Sale : show line 3 in the form 10b5-1 | −2,626 | $49.70 | $130,512 | 18,180 | D |
| Open-market sales · 2,626 sh · avg $49.70 · $130,512 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-12 | Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Units | −6,674 | $0.00 | 6,674 | 0 | D |
| 2025-06-15 | Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Units | −69 | $0.00 | 69 | 274 | D |
Loading xslF345X05/wk-form4_1750116528.xml…